Status not kept up to date
Radio-guided Surgery With DROP-IN Beta Probe for 68Ga-PSMA, in High-risk Prostate Cancer Patients Eligible for Robotic-assisted Radical Prostatectomy.
NCT05596851 · European Institute of Oncology · Updated 27 Oct 2022
- What is being tested
- Not stated
- For
- Prostate Cancer; Positron Emission Tomography; PSMA
- Kind of study
- Watches patients without assigning a treatment. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years and older. About 15 people. The full rules are on the registry page.
- Where
- Italy
- When
- Starts or started 21 March 2022, ends 1 Dec 2023. Registered 27 Oct 2022.
- Results
- None posted yet.
In the researchers' words
The goal of this observational study is to evaluate the diagnostic efficacy and the safety of the combined approach with β-probe and 68Ga-PSMA-11 PET/CT in the correct identification of lymph node metastases, in high-risk prostate cancer patients undergoing radical prostatectomy and pelvic lymph node dissection.
Sites
- IEO European Institute of OncologyMilan, Italy